76 related articles for article (PubMed ID: 1300022)
1. [Study on the toxicity and antitumor activity of adriamycin-DNA and amsacrine-DNA complexes in mice].
Zhang XG; Wu DZ
Yao Xue Xue Bao; 1992; 27(11):801-5. PubMed ID: 1300022
[TBL] [Abstract][Full Text] [Related]
2. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
[TBL] [Abstract][Full Text] [Related]
3. Comparative toxicity of adriamycin and adriamycin-DNA in rats.
Giroux L; Smeesters C; Boury F; Jean G
Rev Can Biol Exp; 1983 Mar; 42(1):67-72. PubMed ID: 6603633
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG
Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for murine ovarian cancer: a rationale for ip therapy with adriamycin.
Ozols RF; Locker GY; Doroshow JH; Grotzinger KR; Myers CE; Fisher RI; Young RC
Cancer Treat Rep; 1979 Feb; 63(2):269-73. PubMed ID: 445504
[TBL] [Abstract][Full Text] [Related]
6. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line.
de Jong S; Zijlstra JG; de Vries EG; Mulder NH
Cancer Res; 1990 Jan; 50(2):304-9. PubMed ID: 1967222
[TBL] [Abstract][Full Text] [Related]
7. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood.
Yokoyama M; Okano T; Sakurai Y; Ekimoto H; Shibazaki C; Kataoka K
Cancer Res; 1991 Jun; 51(12):3229-36. PubMed ID: 2039998
[TBL] [Abstract][Full Text] [Related]
8. Protection from adriamycin cytotoxicity in L1210 cells by brefeldin A.
Vichi PJ; Tritton TR
Cancer Res; 1993 Nov; 53(21):5237-43. PubMed ID: 8106144
[TBL] [Abstract][Full Text] [Related]
9. Radical dimer rescue of toxicity and improved therapeutic index of adriamycin in tumor-bearing mice.
Averbuch SD; Gaudiano G; Koch TH; Bachur NR
Cancer Res; 1985 Dec; 45(12 Pt 1):6200-4. PubMed ID: 4063971
[TBL] [Abstract][Full Text] [Related]
10. [Effect of adriamycin combined with 40 and 43 degrees C hyperthermia on cultured V79 cells and S-180 tumor and their uptake of the drug].
Yoshida M
Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Sep; 51(9):1098-104. PubMed ID: 1945791
[TBL] [Abstract][Full Text] [Related]
11. Increased relative effectiveness of doxorubicin against slowly proliferating sarcoma 180 cells after prolonged drug exposure.
Ritch PS; Occhipinti SJ; Skramstad KS; Shackney SE
Cancer Treat Rep; 1982 May; 66(5):1159-68. PubMed ID: 7083218
[TBL] [Abstract][Full Text] [Related]
12. Modulation by adriamycin, daunomycin, verapamil, and trifluoperazine of the biochemical processes linked to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
Satyamoorthy K; Perchellet JP
Cancer Res; 1989 Oct; 49(19):5364-70. PubMed ID: 2475247
[TBL] [Abstract][Full Text] [Related]
13. Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity.
Tangpong J; Cole MP; Sultana R; Joshi G; Estus S; Vore M; St Clair W; Ratanachaiyavong S; St Clair DK; Butterfield DA
Neurobiol Dis; 2006 Jul; 23(1):127-39. PubMed ID: 16697651
[TBL] [Abstract][Full Text] [Related]
14. Comparison of antitumor properties of nitracrine and amsacrine analogs.
Mazerska Z; Chołody M; Lukowicz J; Wysocka-Skrzela B; Ledóchowski A
Arzneimittelforschung; 1987 Nov; 37(11):1276-81. PubMed ID: 3326605
[TBL] [Abstract][Full Text] [Related]
15. Polybutylcyanoacrylate magnetic nanoparticles as carriers of adriamycin.
Cai L; Niu G; Hu Z; Jin W; Wang J; Sun L
J Drug Target; 2009 Apr; 17(3):200-6. PubMed ID: 19558359
[TBL] [Abstract][Full Text] [Related]
16. Coenzyme Q10 and adriamycin toxicity in mice.
Shaeffer J; El-Mahdi AM; Nichols RK
Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):309-15. PubMed ID: 7414051
[TBL] [Abstract][Full Text] [Related]
17. Direct antitumor effect of cepharanthin and combined effect with adriamycin against Ehrlich ascites tumor in mice.
Asaumi J; Nishikawa K; Matsuoka H; Iwata M; Kawasaki S; Hiraki Y; Nishijima K
Anticancer Res; 1995; 15(1):67-70. PubMed ID: 7733643
[TBL] [Abstract][Full Text] [Related]
18. The comparative toxicity and therapeutic efficacy of adriamycin and the adriamycin-DNA complex in the chemotherapy of C3H mice with transplanted mammary adenocarcinoma.
Brown I; Ward HW
Cancer Lett; 1977 Mar; 2(4-5):227-32. PubMed ID: 45724
[TBL] [Abstract][Full Text] [Related]
19. Glutathione elevation by gamma-glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: Implication for chemobrain.
Joshi G; Hardas S; Sultana R; St Clair DK; Vore M; Butterfield DA
J Neurosci Res; 2007 Feb; 85(3):497-503. PubMed ID: 17171703
[TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy targeting regional lymph nodes by gastric submucosal injection of liposomal adriamycin in patients with gastric cancer].
Akamo Y; Mizuno I; Takeyama H; Mohri N; Ueda T; Shibata T; Yotsuyanagi T; Manabe T
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1712-4. PubMed ID: 9382513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
